PubMed:26685104 / 2090-2266 JSONTXT

Annnotations TAB JSON ListView MergeView

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T10","span":{"begin":0,"end":176},"obj":"DRI_Outcome"}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T17","span":{"begin":0,"end":176},"obj":"Sentence"},{"id":"T17","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T17","span":{"begin":0,"end":176},"obj":"Sentence"},{"id":"T17","span":{"begin":0,"end":176},"obj":"Sentence"}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}

    Preeclampsia

    {"project":"Preeclampsia","denotations":[{"id":"PD-Preeclampsia-B_T6","span":{"begin":68,"end":80},"obj":"ORPHA:275555"},{"id":"PD-Preeclampsia-B_T7","span":{"begin":153,"end":165},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}

    Preeclampsia-compare

    {"project":"Preeclampsia-compare","denotations":[{"id":"PD-Preeclampsia-B_T6","span":{"begin":68,"end":80},"obj":"ORPHA:275555"},{"id":"PD-Preeclampsia-B_T7","span":{"begin":153,"end":165},"obj":"ORPHA:275555"}],"namespaces":[{"prefix":"ORPHA","uri":"www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN\u0026Expert="}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}

    UBERON-AE

    {"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T14","span":{"begin":32,"end":35},"obj":"http://purl.obolibrary.org/obo/UBERON_2001977"}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}

    performance-test

    {"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T17","span":{"begin":32,"end":35},"obj":"http://purl.obolibrary.org/obo/UBERON_2001977"}],"text":"These data demonstrate that PLX-PAD cell therapy can safely reverse preeclampsia-like features during pregnancy and have a potential therapeutic role in preeclampsia treatment."}